Preimplantation genetic screening should be used in all in vitro fertilisation cycles in women over the age of 35 years: FOR: Optimising reproductive outcomes is cost-effective and minimises adverse sequelae
Главные авторы: | , , , |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Wiley
2019
|